StreetInsider.com News Articles

Form 15F-12B Olink Holding AB (publ)

Mon, 22 Jul 2024 17:20:00 -0400

si-local-file:///var/storage/secattach/20240722/23489532.html

Form 15F-12B Olink Holding AB (publ)

Mon, 22 Jul 2024 17:20:00 -0400

si-local-file:///var/storage/secattach/20240722/23489532.html

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

BURLINGTON, Mass., July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Mon, 22 Jul 2024 16:05:00 -0400

Azenta will provide proteomics technology profiling on up to 20,000 individuals.

In collaboration with the University of Helsinki, the organization leading the FinnGen study, Azenta will provide

Form 6-K Olink Holding AB (publ) For: Jul 22

Mon, 22 Jul 2024 08:30:00 -0400

si-local-file:///var/storage/secattach/20240722/23486615.html

Form 6-K Olink Holding AB (publ) For: Jul 22

Mon, 22 Jul 2024 08:30:00 -0400

si-local-file:///var/storage/secattach/20240722/23486615.html

Form SC 14D9/A Olink Holding AB (publ) Filed by: Olink Holding AB (publ)

Wed, 17 Jul 2024 08:31:00 -0400

si-local-file:///var/storage/secattach/20240717/23472439.html

Form SC 14D9/A Olink Holding AB (publ) Filed by: Olink Holding AB (publ)

Wed, 17 Jul 2024 08:31:00 -0400

si-local-file:///var/storage/secattach/20240717/23472439.html

Form SC TO-T/A Olink Holding AB (publ) Filed by: THERMO FISHER SCIENTIFIC INC.

Wed, 17 Jul 2024 07:41:00 -0400

si-local-file:///var/storage/secattach/20240717/23472087.html

Form SC TO-T/A Olink Holding AB (publ) Filed by: THERMO FISHER SCIENTIFIC INC.

Wed, 17 Jul 2024 07:41:00 -0400

si-local-file:///var/storage/secattach/20240717/23472087.html

Form 6-K Olink Holding AB (publ) For: Jul 11

Thu, 11 Jul 2024 17:23:00 -0400

si-local-file:///var/storage/secattach/20240711/23456723.html

Form 6-K Olink Holding AB (publ) For: Jul 11

Thu, 11 Jul 2024 17:23:00 -0400

si-local-file:///var/storage/secattach/20240711/23456723.html

Notice to attend the Extra General Meeting of Olink Holding AB (publ)

Thu, 11 Jul 2024 16:05:00 -0400

This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.

UPPSALA, Sweden, July 11, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the "Company"), reg. no. 559189-7755, are hereby given notice to attend the Extra General Meeting to be held at 4:00 p.m. CEST on Tuesday 6 August 2024, in the Company's facilities at Salagatan 16F, Uppsala. Registration for the meeting commences at 3:30 p.m. CEST.

NOTICE OF PARTICIPATION

Shareholders who wish to attend in the proceedings of the